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Zürich, Zurich, Switzerland; 9Royal Children’s Hospital, Parkville, Australia; 10Centre
for Infectious Diseases and Microbiology Laboratory Services, Westmead Hospital and
University of Sydney, Westmead, Australia; 11Institute of Environmental Science and
Research, National Centre for Biosecurity and Infectious Disease, Upper Hutt, New
Zealand; 12Microbiology Department, Canterbury Health Laboratories, Christchurch,
New Zealand; 13Virology Division, SEALS Microbiology, Prince of Wales Hospital, Sydney,
Australia; 14School of Population and Global Health, University of Melbourne, Melbourne,
Australia; 15School of Biological Sciences, Nanyang Technological University, Singapore,
Singapore; 16National Public Health Laboratory, Communicable Diseases Division,
Ministry of Health, Singapore, Singapore; 17Duke Global Health Institute, Duke
University, Durham, United States; 18School of Applied Sciences and Engineering,
Monash University, Churchill, Australia
Abstract A complex interplay of viral, host, and ecological factors shapes the spatio-temporal
incidence and evolution of human influenza viruses. Although considerable attention has been paid
to influenza A viruses, a lack of equivalent data means that an integrated evolutionary and
epidemiological framework has until now not been available for influenza B viruses, despite their
significant disease burden. Through the analysis of over 900 full genomes from an epidemiological
collection of more than 26,000 strains from Australia and New Zealand, we reveal fundamental
differences in the phylodynamics of the two co-circulating lineages of influenza B virus (Victoria and
Yamagata), showing that their individual dynamics are determined by a complex relationship
between virus transmission, age of infection, and receptor binding preference. In sum, this work
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Introduction
In addition to two subtypes of influenza A virus (H1N1 and H3N2), two lineages of influenza
B viruses co-circulate in humans and cause seasonal influenza epidemics (Klimov et al., 2012).
Influenza B causes a significant proportion of influenza-associated morbidity and mortality, and in
some years is responsible for the major disease burden (Burnham et al., 2013; Paul Glezen et al.,
2013). Although type A and B influenza viruses are closely related and have similarities in genome
organization and protein structure (McCauley et al., 2012), they exhibit important differences in
their ecology and evolution (Chen and Holmes, 2008; Tan et al., 2013). While new influenza
A viruses periodically emerge from animal reservoirs to become endemic in humans (Neumann
et al., 2009; Smith et al., 2009), influenza B viruses, first recognized in 1940, have circulated
continuously in humans alongside influenza A viruses and are presumably derived from a single, as
yet unknown, source (Francis, 1940; Chen and Holmes, 2008). Unlike influenza A viruses that can
infect a wide range of species, influenza B infections are almost exclusively restricted to humans with
only sporadic infections reported in wildlife (Osterhaus et al., 2000; Bodewes et al., 2013). While
the evolutionary and epidemiological dynamics of human influenza A H1N1 and H3N2 viruses have
been well documented at the global scale (Rambaut et al., 2008; Russell et al., 2008;
Bedford et al., 2010; Bahl et al., 2011), the equivalent dynamics of the two influenza B virus
lineages—B/Yamagata/16/88-like and B/Victoria/2/87-like, henceforth termed the Yamagata and
Victoria viruses—are poorly understood.
eLife digest To develop new therapies against infections caused by a virus, it is important to
understand the virus’s history—where, when, and why it has caused disease and how it has changed
over time. For example, new human strains of the influenza type A virus originate from strains that
infect animals and rapidly can become common in human populations. In contrast, influenza type B
virus strains almost exclusively infect humans and are continuously present in human populations.
Both types have a detrimental impact on global health, but the type B viruses are less well
understood, partly because outbreaks have not been as extensively documented.
Vijaykrishna et al. have now investigated the history of the two strains of the influenza type B
virus—called Victoria and Yamagata—that currently circulate in humans. To do this, they inspected
the genetic sequences of 908 viruses taken from samples of confirmed type B infections collected
across Australia and New Zealand over 13 years.
Individual virus particles of the same strain have genetic sequences that are very similar, but not
completely identical. Vijaykrishna et al. showed that the diversity of the genetic sequences from the
Victoria strain fluctuated between seasons, and particular genetic variants of Victoria only persisted
in the population for 1–3 years. This indicates that Victoria viruses are under a lot of pressure to
evolve, which results in so-called ‘bottlenecks’ whereby only the viruses carrying particular varieties
of genetic sequence survive. This fluctuating pattern resembles that of the better-understood type A
seasonal flu strain H3N2.
On the other hand, there was little change in the genetic diversity of the Yamagata strains
sampled over the same 13-year period. The Yamagata viruses have diversified to a greater extent
and several different ‘varieties’ of the virus tend to circulate together for long periods of time. For
example, the three varieties of Yamagata virus circulating in 2013 evolved from a common parent
virus that was circulating around 10 years ago.
Vijaykrishna et al. found that between disease outbreaks, there was greater variation in the ability
of Victoria viruses to be transmitted in humans, but that they were generally more easily transmitted
than the Yamagata viruses. Victoria viruses tend to infect younger patients than Yamagata viruses,
which is thought to be due to differences in the molecules that help the viruses enter the cells of the
respiratory tract.
These findings suggests that it might be possible to eradicate the more slowly evolving influenza
B Yamagata virus through mass vaccination programs using existing vaccines. This would then allow
researchers to focus on developing effective vaccines to target the other strains of influenza virus.
DOI: 10.7554/eLife.05055.002
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Human influenza A H3N2 viruses exhibit limited genetic diversity at individual time-points due to
periodic bottlenecks caused by strong selection—known as ‘antigenic drift’—in the hemagglutinin (HA)
and neuraminidase (NA) genes. This results in an HA phylogenetic tree with a characteristic slender
‘trunk’ (Fitch et al., 1997) appearance (Figure 1A). H3N2 viruses also exhibit strong seasonal
fluctuations in genetic diversity in temperate climate regions (such as Australia and New Zealand)
(Rambaut et al., 2008), mainly due to the local extinction of viral lineages at the end of each influenza
season (Rambaut et al., 2008). A similar but weaker evolutionary pattern is observed in the seasonal
H1N1 viruses that have circulated in humans for the majority of the previous century (1918–1957 and
1977–2009), with short-term co-circulation of diverging virus populations (Nelson et al., 2008b)
(Figure 1B). The pandemic H1N1 (H1N1pdm09) viruses have to date also only exhibited limited
antigenic evolution since they emerged in 2009 (Figure 1C). In contrast, influenza B viruses are currently
composed of two distinct lineages (Victoria and Yamagata) (Kanegae et al., 1990; Rota et al., 1990)
(Figure 1D) that diverged approximately 40 years ago and which have since co-circulated on a global
scale, despite frequent reassortment among them (Chen and Holmes, 2008). Although the HA genes of
influenza B viruses are thought to exhibit lower rates of evolutionary change (nucleotide substitution)
than both influenza A viruses (Ferguson et al., 2003; Chen and Holmes, 2008; Bedford et al., 2014),
their antigenic characteristics are not well understood.
The advent of global influenza surveillance and full genome sequencing over the past decade
has shown that seasonal epidemic outbreaks of each influenza type are caused by the stochastic
introduction of multiple virus lineages (Nelson et al., 2008a) and that the patterns of seasonal
oscillation vary between temperate and tropical regions (Rambaut et al., 2008). Population
genetic analysis (Rambaut et al., 2008), consistent with epidemiological data (Goldstein et al.,
2011), suggests that the H3N2 and H1N1 subtypes of influenza A virus compete with each other
resulting in the epidemic dominance of a single subtype. However, it is unclear whether the same
dynamic patterns can be extended to influenza B viruses, or why the Victoria and Yamagata
lineages have co-circulated for such an extended time period.
To understand the evolutionary and epidemiological dynamics of influenza B virus, we generated
the full genomes of 908 influenza B viruses selected from over 26,000 laboratory confirmed influenza
B cases in children and adults aged from birth to 102 years sampled during 2002–2013 in eastern
Figure 1. Evolutionary dynamics of human influenza A and influenza B Victoria and Yamagata viruses. Evolution of
the HA genes of influenza A H3N2 virus, 2002–2013, (A), H1N1 virus, 1998–2009 (B), H1N1pdm09 virus, 2009–2013
(C), and influenza B Yamagata (red) and Victoria (black) lineage viruses, 2002–2013 (D). All phylogenetic trees were
generated using approximately 1200 randomly selected full-length gene sequences sampled during 12 years.
DOI: 10.7554/eLife.05055.003
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Australia (Queensland, n = 275; New South Wales, n = 210; and Victoria, n = 207) and New Zealand
(n = 216) (Figure 2). These regions were selected because influenza surveillance was well established
and continuous during the sampling period and included the co-circulation and periodic dominance of
influenza A and both influenza B virus lineages. Of note is that the influenza B virus strain used for
vaccination in the region did not match the dominant circulating strain during 7 of the 13 years studied
(Figure 2B). Our overall aim was to integrate, for the first time, data obtained from genetic,
epidemiological, and immunological sources to better understand the evolution and interaction of
these two lineages of influenza B virus.
Results and discussion
Population dynamics of influenza B virus
We used the HA segment of both lineages to contrast their phylodynamics. First, to assess the
changing patterns of genetic diversity of the two influenza B virus lineages in relation to their
evolutionary histories, we used a flexible coalescent-based demographic model (Minin et al., 2008),
which revealed stark differences in the epidemiological dynamics of the Victoria and Yamagata
lineages (Figure 3A,B). Whereas the Victoria lineage experienced strong seasonal fluctuations in
Figure 2. Influenza B virus lineages in Australia and New Zealand, 2001–2013 and source of full genomes.
Percentage prevalence of influenza B viruses isolated from the three eastern Australian states and New Zealand
(A). Coloured lines represent the proportion of influenza viruses typed as influenza B in each country (blue) and each
of the eastern Australian states; Queensland (yellow), New South Wales (orange), and Victoria (pink). Bars represent
the percentage prevalence of Victoria (black) and Yamagata (red). Data based on National Notifiable Diseases
Surveillance system (NNDSS) for Australia and Environmental Science and Research (ESR) for New Zealand. The
lineage of representative influenza B virus strains used in the trivalent influenza vaccine during these years in both
countries (B). Excluding the years 2003 and 2009, influenza B viruses represented on average 24.6% (range
9.5–53.7%) and 31.5% (range 0.5–86.9%) of laboratory confirmed influenza viruses from Australia and New Zealand,
respectively. The percentage of circulating influenza viruses that were influenza B was significantly lower in 2003
(AUS, 3.4%) and 2009 (AUS, 0.8%) than in other years, due to the dominance of a new H3N2 variant (A/Fujian/412/
2002-like) in 2003 and the emergence of the H1N1 pandemic in 2009. Source of full genomes of Victoria and
Yamagata viruses (C).
DOI: 10.7554/eLife.05055.004
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relative genetic diversity, little change was observed over the same time period for the Yamagata
lineage, and these observations were not heavily affected by differences in sampling density
(Figure 3—figure supplement 1). While the almost invariant relative genetic diversity of the
Yamagata lineage resembled that of seasonal H1N1 viruses (Figure 3D), the stark and almost annual
changes of diversity in the Victoria lineage were similar to those observed for H3N2 virus (Figure 3C);
although H3N2 viruses exhibited a greater frequency of oscillations than those estimated for Victoria
lineage viruses. The strong seasonal fluctuations in diversity observed for Victoria lineage suggest that
this lineage experiences strong bottlenecks between seasons similar to those described for H3N2
viruses (Bedford et al., 2011; Zinder et al., 2013), whereas the almost invariant relative genetic
diversity for Yamagata suggests the continuous co-circulation of multiple lineages.
Marked differences between the Victoria and Yamagata lineages were apparent in phylogenetic
trees of the HA (Figure 4). The phylogenetic analysis of the HA genes showed that the Victoria lineage
was characterized by a single prominent tree ‘trunk’, with side branches that circulated for short
periods of time (1–3 years) (Figure 4). This evolutionary pattern parallels that observed for seasonal
H3N2 viruses and is indicative of frequent selective bottlenecks due to the serial replacement of
circulating strains, as would be expected under continual antigenic drift (Grenfell et al., 2004).
In contrast, greater diversification was observed for the Yamagata lineage, with multiple clades
co-circulating for extensive periods of time (Figure 4). For example, the three clades of Yamagata
viruses circulating in 2013 diverged approximately 10 years ago, again paralleling the evolutionary
pattern seen in seasonal H1N1 viruses. These patterns are clearly identifiable in the genealogical
diversity skyline (Figure 4) in which the average time to common ancestor between contemporaneous
samples fluctuated from 0 to <5 years for Victoria lineage, except during 2010 and 2011 where the
Figure 3. Population dynamics of genetic diversity in Australia and New Zealand. The relative genetic diversity of the
HA segments of influenza B Victoria (A), Yamagata (B) and influenza A H3N2 (C), and H1N1 2003–2008 and
H1N1pdm09 2009–2013 viruses (D), isolated in Australia and New Zealand using the Gaussian Markov Random Field
(GMRF) model.
DOI: 10.7554/eLife.05055.005
The following figure supplement is available for figure 3:
Figure supplement 1. Effect of sampling on the population dynamics of Influenza B virus.
DOI: 10.7554/eLife.05055.006
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genealogical diversity marginally increased to 7 years. In contrast, the genealogical diversity of
Yamagata was consistently greater and gradually increased during the sampling period. The
maintenance of genetic diversity through epidemic peaks and troughs as described for Yamagata
(Figure 3B) is expected to result in the gradual increase of divergence times of contemporaneous
samples.
Transmission dynamics of influenza B virus
As each seasonal influenza epidemic provides important information on the epidemiological
characteristics of both influenza B virus lineages, we utilized a birth–death susceptible-infected-
removed (BDSIR) (Kühnert et al., 2014) phylodynamic model that simultaneously co-estimates
seasonal phylogenies along with the basic reproductive number, R0, for each lineage. However,
because the infected population contains both susceptible and non-susceptible hosts we report the
effective reproductive number, Re. This analysis showed a greater variation in Re (median values,
1.1–1.3) between epidemics caused by the Victoria lineage, whereas the Re of Yamagata epidemics,
were generally lower, varied only slightly, around 1.1 (1.08–1.14) (Figure 5A), indicating greater
heterogeneity in transmission between seasons for Victoria viruses. Years in which both influenza
viruses co-circulated in sufficient numbers (2005 and 2008) offer a chance for direct comparison of
their phylodynamics. Both lineages transmitted with nearly equal force in 2005, whereas in 2008 the
median Re of 1.27 (95% highest posterior density [HPD] of 1.18–1.37) estimated for the Victoria
lineage was significantly greater than that of Yamagata at 1.11 (95% HPD 1.05–1.17). Analysis of the
Figure 4. Evolution of the hemagglutinin genes of influenza B viruses. Phylogenetic relationship of the HA genes of
influenza B Victoria (black) and Yamagata (red) lineage viruses inferred using the uncorrelated lognormal relaxed
clock model. Genetic diversity through time was estimated by averaging the pairwise distance in time between
random contemporaneous samples with a 1-month window on the same dated Maximum clade credibility (MCC)
trees.
DOI: 10.7554/eLife.05055.007
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cumulative number of all influenza B positive cases through time for each season (Figure 5B) reveals
significant differences in the exponential growth phase between the lineages, where Victoria lineage
exhibited significantly higher initial growth rate resulting in a faster epidemic with larger number of
infections. These results also show that in 2008 the Victoria lineage exhibited a significantly faster
growth rate, in correlation with the high Re, coinciding with the year in which a new antigenic variant of
the Victoria lineage was first detected (B/Brisbane/60/2008-like viruses) in Australia and New Zealand.
This antigenic variant emerged as the globally dominant influenza B strain in the following years and
has been continuously recommended (2009–2015) as the influenza B vaccine component since that
period in both the Northern and Southern Hemispheres (Klimov et al., 2012).
The BDSIR model assumes a closed epidemic, but the large-scale phylogenies generated using all
available global data indicated that each of the annual epidemics were caused by the introduction of
multiple viral lineages that went extinct locally by the end of the seasonal epidemic (data not shown).
We therefore investigated the effect of virus migration on the estimates of Re. First, we identified
lineages that conformed to the assumption of a closed epidemic (i.e., lineages resulting from a single
introduction into Australia and New Zealand) and with a sufficiently large local transmission for
analysis (i.e., Victoria lineage viruses in 2005, 2006 and 2008). An independent estimation of Re for
each of these lineages produced a minor but non-significant variation to those observed for the entire
epidemic (Figure 5—figure supplement 1B), indicating that, on average, the Re estimates for
lineages resulting from multiple introductions were similar. Next, we used a continuous-time Markov
chain (CTMC) phylogeographic process (Minin and Suchard, 2008) to estimate the number of
migration events into and from Australia and New Zealand during the same period (Figure 6).
This indicated that the number of introductions per year was greater for the Yamagata lineage
(15–22, mean state transition count in all years) than for Victoria (3–8, except 16 and 14 during 2010
and 2011, respectively) (Figure 6), further suggesting an inverse relationship between Re (Figure 5)
and the number of introduction events. Indeed, our results show that introductions of viruses with
greater transmission efficiency (i.e., high Re), such as Victoria/2008, resulted in the epidemic
dominance of such single strains, whereas epidemics of the Yamagata lineage with lower Re values
likely resulted in slower and shorter transmission chains with reduced competition, in turn allowing the
co-circulation (and detection) of multiple introduced lineages. Additionally, we identified that,
combined, Australia and New Zealand were net importers of influenza viruses, except during 2002
and 2008 when the net export of the Victoria lineage was similar to the import observed during the
Figure 5. Phylodynamics and cumulative cases of influenza B viruses. Effective reproductive number (Re) of influenza B Victoria (black) and Yamagata (red)
viruses (of the HA data set) estimated for single epidemics (median and 95% highest posterior density (HPD) values) during years with sufficient number of
sequences estimated using the BDSIR model (A). The cumulative number of cases from all influenza B virus positive samples for each of these years (B).
DOI: 10.7554/eLife.05055.008
The following figure supplement is available for figure 5:
Figure supplement 1. Estimates of Re with various S0 values.
DOI: 10.7554/eLife.05055.009
Vijaykrishna et al. eLife 2015;4:e05055. DOI: 10.7554/eLife.05055 7 of 23
Research article Genomics and evolutionary biology | Microbiology and infectious disease
same years (Figure 6). The higher transmission rate for Victoria/2008 viruses (i.e., B/Brisbane/60/2008-
like viruses) may have also caused the successful seeding of these viruses globally (as described
above). Taken together, our results support the concept of a global metapopulation seeding
subsequent epidemics elsewhere (Bedford et al., 2010; Bahl et al., 2011), provided the virus is
transmitted efficiently as observed during 2008 in this study.
Genome-wide evolutionary dynamics of influenza B viruses
To understand the genome-wide evolutionary dynamics of the two influenza B virus lineages, we
inferred temporal changes in genetic diversity for all remaining gene segments (Figure 7). These
analyses showed that the patterns observed for the NA and internal gene segments were similar to
those observed for the HA genes described above. The single exception was the NP genes of both
lineages where substantial differences occurred throughout their history. During 2002–2007, the
peaks of relative genetic diversity of the Victoria NP was higher than all remaining gene segments
following which this lineage was not identified in our surveillance, whereas the Yamagata NP showed
additional peaks during 2010 and 2011 that corresponded to the NP peaks observed for the Victoria
genes.
As genomic reassortment impacts levels of genetic diversity, we conducted phylogenetic analyses
of all eight genome segments of the 908 viruses. Comparison of these phylogenies revealed frequent
reassortment within the two lineages of influenza B virus (data not shown) and a few instances of
reassortment between them (Figure 8). During the sampling period, the Victoria lineage HA gene
repeatedly acquired internal gene segments from Yamagata lineage viruses to form novel
reassortants. In particular, during 2004 a subpopulation (approximately 15%) of Victoria-like viruses
acquired all internal gene segments (PB2, PB1, PA, NP, MP, and NS) from the Yamagata lineage
viruses. Interestingly, all remaining inter-lineage reassortment events of the Victoria HA lineages
involved the acquisition of the Yamagata NP gene during 2007 and 2008 (Figure 8E), which resulted
in the extinction of the previously circulating Victoria lineage NP gene. These patterns were consistent
with the reconstruction of the population genetic history for the NP gene where we observed
additional peaks in genetic diversity following 2007/2008 when the Yamagata NP was acquired by
Victoria viruses (Figure 7), indicating a major genome-level transition for Victoria lineage viruses. In
contrast, the only inter-lineage reassortment events for the virus carrying the Yamagata HA occurred
during 2002 and 2004 (red arrows in Figure 8A,F), when the NA and MP genes were derived from the
Victoria lineage viruses, but these viruses went extinct within the same influenza season. In sum, these
results show that the HA gene of Victoria viruses is placed in different genetic backgrounds at a higher
rate and this is likely to have important fitness consequences.
Figure 6. Estimation of migration of influenza B viruses into and out of Australia and New Zealand. Estimated counts of
import and export of Victoria (black) and Yamagata (red) between Australia and New Zealand and rest of the world,
using the HA gene data set. Error bars represent the 95% highest posterior density (HPD) values of each point.
DOI: 10.7554/eLife.05055.010
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Phylogenies also suggest that the PB2 and PB1 gene trees (Figure 8B,C) exhibit deep divergence,
similar to the HA gene where co-circulating viruses contain distinct Victoria and Yamagata genes. In
contrast, the other gene segments exhibit relatively recent divergence indicating that the prevailing
diversity of these genes originates from a single lineage. These results are consistent with a detailed
investigation of long term reassortment patterns of influenza B virus lineages that revealed genetic
linkage between the PB2, PB1 and HA protein genes (Dudas et al., 2015). Specifically, we observe
that the PB2, PB1 and HA genes were consistently derived from a single lineage, except for the
short-lived subpopulation in 2004.
Differential selection pressure between lineages
Despite the marked differences in their epidemiological and evolutionary dynamics, the HA genes of
the two influenza B lineages both evolved at a rate of approximately 2.0 × 10−3 subs/site/year
(Table 1), comparable to those previously estimated for a smaller (n = 102) global sample of influenza
B viruses collected during 1989–2006 (Chen and Holmes, 2008) (mean nucleotide substitution rate of
2.15 × 10−3 subs/site/year). These rates were considerably lower than those estimated for influenza A
H3N2 and H1N1 viruses (5.5 × 10−3 subs/site/year, 4.0 × 10−3 subs/site/year, respectively) (Rambaut
et al., 2008). In contrast, analysis of the ratio of the number of nonsynonymous and synonymous
substitutions per site (dN/dS) revealed significant differences between the influenza B virus lineages,
with the Victoria lineage viruses having accumulated more nonsynonymous substitutions (dN/dS = 0.19)
than the Yamagata lineage (dN/dS = 0.13) (p-value, <0.05). In addition, two amino acid residues in the
Victoria HA (positions 212 and 214) were revealed to have experienced positive selection (p < 0.05),
whereas no positively selected sites were observed in the Yamagata lineage over the time period
studied. Similarly, the Victoria lineage exhibited a greater dN/dS (ratio = 1.37) on internal vs external
branches of the HA phylogeny compared to the Yamagata lineage (ratio = 0.98), indicating that amino
acid changes have been fixed more frequently in Victoria than Yamagata lineage viruses (Table 1). Taken
together, these results indicate that the Victoria lineage is under greater positive selection pressure, and
hence likely to experience greater antigenic drift, than the more conserved Yamagata lineage.
Figure 7. Genome wide evolutionary dynamics—relative genetic diversity. Relative genetic diversity of each gene
segments of Victoria (black) and Yamagata (red) lineages estimated using the Gaussian Markov Random Fields
(GMRF) Skyride model (as in Figure 3).
DOI: 10.7554/eLife.05055.011
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Antigenic evolution
We constructed antigenic maps (Smith et al., 2004) using hemagglutination inhibition (HI) assay
measurements for 87 Victoria and Yamagata viruses isolated during 2002–2013 and using 20 reference
antigens and antisera (Figure 9A). These revealed that Victoria lineage viruses exhibited antigenic variation
that generally clustered according to the year of isolation and phylogenetic distance, indicative of ongoing
antigenic drift, and similar to that previously reported for H3N2 viruses (Smith et al., 2004; Bedford et al.,
2014). In contrast, the antigenic distances for the Yamagata viruses had no correlation with time or
phylogenetic distance and showed greater levels of antigenic cross-reactivity between antisera raised to
both earlier and more recent viruses. Structural modeling showed that the degree of antigenic distance
between strains of Victoria viruses was often linked to the proximity of single amino acid substitutions to
the receptor binding pocket (RBP) of the HA (Figure 9B; see structural differences section below), in
agreement with recent work on H3N2 (Koel et al., 2013). Importantly, the closer the amino acid change
between two strains was to the RBP, the greater the antigenic difference between them.
Heterogeneous age distributions of the lineages
In addition to genetic, antigenic, and evolutionary differences, we found a notable difference in the
age distribution of infected cases for the two influenza B virus lineages (Figure 10) that was generally
Figure 8. Genome wide evolutionary dynamics—reassortment. Evolutionary relationships of neuraminidase
(A), polymerase basic 2 (B), polymerase basic 1 (C), polymerase acidic (D), nucleoprotein (E), matrix (F), and
non-structural (G) genes of Victoria and Yamagata lineage viruses inferred using the maximum likelihood analysis of
908 full genome sequences. Lineages are coloured based on the HA lineage: Victoria (black) and Yamagata (red)
and arrows highlight inter-lineage reassortment.
DOI: 10.7554/eLife.05055.012
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consistent throughout our sampling period (Figure 10—figure supplement 1). On average, Victoria
viruses infected a younger population (mean 16.8 years, median 11 years) compared to Yamagata
viruses (mean 26.6 years, median 18 years). Although the proportion of cases under 6 years were
similar in both lineages (28.8% of Victoria and 26.8% of Yamagata), there were 1.7 times more cases
aged 6–17 years infected with a Victoria lineage virus (39.0% Victoria vs 22.7% Yamagata), while this
ratio was almost reversed for those aged 18 years and over (32.2% Victoria vs 50.0% Yamagata; χ2,
p < 0.0001) (Table 2). Thus, nearly 70% of Victoria lineage viruses were identified in children
<18 years, whereas the Yamagata lineage exhibited a bimodal age distribution with a significant
shift toward infections in individuals aged >25 years (Figure 10). These differences in age
distribution are significant and unlikely to be explained by systematic bias because the same pattern
was observed in both countries, and are consistent with data from Guangdong, China (Tan et al.,
2013), and Slovenia (Sočan et al., 2014) during the 2009–2010 and 2010–2013 epidemic seasons,
respectively.
A direct consequence of antigenic drift is the possibility for previously infected individuals to
become reinfected. Subsequently, higher rates of antigenic drift in the Victoria lineage should lead to
a more even age distribution of cases, whereas lower rates of antigenic drift should lead to an age
distribution of cases that are skewed towards younger individuals. Although viruses of the Victoria
lineage were consistently reported at a higher frequency during our surveillance period, the observed
skew towards children runs counter to this expectation (Figure 10). One possible explanation is that
the higher Re of the Victoria viruses reduces the mean age of infection, as expected in the case of
a disease like influenza that imparts some immunity following infection (Anderson and May, 1992).
Alternatively, the inability of Victoria viruses to infect an equivalent proportion of other age groups
may mean that the relatively older population is better protected against this virus because of
a broader immune response. The former scenario is supported by an increase in the mean age of
infection from 15 years (median, 12) in 2008 to 20.5 years (median, 14) in 2011 for the B/Brisbane/60/
Table 1. Nucleotide substitution rates (nucleotide substitutions/site/year) and selection pressures (dN/dS) of influenza B viruses from
Australia and New Zealand during 2002–2013
Mean substitution rates Branch dN/dS Site dN/dS
Segment* (95% HPD) Global dN/dS Internal External Internal/External No. +ve (sites) No. −ve
Victoria
PB2 1.49 (1.28–1.69) 0.08 (0.07–0.09) 0.02 0.03 0.55 0 373
PB1 0.14 (0.12–0.16) 0.08 (0.07–0.09) 0.06 0.05 1.08 1 (474) 402
PA 1.65 (1.44–1.88) 0.13 (0.11–0.15) 0.08 0.08 1.03 1 (700) 334
HA 2.00 (1.74–2.57) 0.19 (0.17–0.22) 0.12 0.09 1.37 2 (212, 214) 239
NP 1.04 (0.76–1.34) 0.09 (0.07–0.12) 0.07 0.05 1.22 0 49
NA 2.04 (1.72–2.36) 0.31 (0.28–0.35) 0.25 0.24 1.02 6 (46, 73, 106, 145, 146, 395) 129
MP 1.44 (1.17–1.70) 0.06 (0.04–0.09) 0.00 0.02 0.01 0 87
NS 1.71 (1.38–2.06) 0.45 (0.38–0.53) 0.11 0.30 0.37 3 (116, 120, 249) 13
Yamagata
PB2 2.00 (1.74–2.25) 0.06 (0.05–0.07) 0.03 0.02 1.44 0 443
PB1 1.78 (1.56–2.00) 0.07 (0.05–0.08) 0.02 0.03 0.82 1 (357) 392
PA 1.60 (1.35–1.84) 0.10 (0.08–0.12) 0.03 0.05 0.57 0 204
HA 2.01 (1.73–2.29) 0.13 (0.11–0.16) 0.07 0.07 0.98 0 245
NP 1.87 (1.65–2.10) 0.10 (0.08–0.11) 0.08 0.07 1.16 0 308
NA 2.25 (1.90–2.60) 0.20 (0.17–0.24) 0.30 0.18 1.70 1 (295) 124
MP 2.20 (1.85–2.55) 0.05 (0.03–0.07) 0.05 0.02 2.08 0 102
NS 2.00 (1.66–2.39) 0.33 (1.66–2.39) 0.42 0.32 1.32 0 30
*Analysis was restricted to the non-overlapping regions of M1 and NS1, for the MP and NS segments, respectively.
DOI: 10.7554/eLife.05055.013
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2008-like antigenic variant of the Victoria lineage, which coincided with a gradual drop in Re from its
peak in 2008 (Figure 5A).
Structural differences among influenza B viruses
Finally, we sought to determine whether differences in the evolutionary and epidemiological dynamics
between the two influenza B lineages resulted from variation in HA structure and binding preferences.
First, we compared amino acid substitutions per site within and between influenza virus lineages from
2002 to 2012 and mapped these onto structural models of representative influenza B virus strains
(Figure 11). The higher rates of amino acid change observed in the Victoria HA (Figure 11A) were
consistent with the stronger selective pressures on this viral lineage. Importantly, these changes
occurred in three major clusters situated around 21, 29, and 37 Å to the RBP of the HA domain that
Figure 9. Antigenicity of influenza B viruses. Antigenic map showing relative antigenic differences of Victoria and
Yamagata lineage viruses (circles) measured using the hemagglutinin inhibition (HI) assay for each strain and
coloured by year of isolation (A). Residues contributing to HI titer changes (B). Among the nine amino acid changes
that we detected between antigenically different Victoria viruses, three changes produced strong HI titer change
(>100) (red), 3 medium (≈50) (orange) and 3 low (<20) (yellow). Changes that produced the strongest HI titer change
were the closest to the receptor binding pocket (blue arrow), highlighting the significance of their proximity to HI
titer change. Amino acids were mapped on previously resolved influenza B virus structure (PDB:4FQM). Detailed HI
titer values and reference antigens used are provided in the Dryad source data (Vijaykrishna et al., 2015).
DOI: 10.7554/eLife.05055.014
Figure 10. Age distribution of influenza B viruses. Density of age distribution of influenza B virus positive samples of
Victoria (black) and Yamagata (red) lineages, collected from Australia and New Zealand during 2002–2013. Patient
age was available for 5260 samples. The age distributions by lineage were compared by histogram using 2-year bins.
Also see Table 2 for comparison by age categories and Dryad source data for mean and median age for each year.
DOI: 10.7554/eLife.05055.015
The following figure supplement is available for figure 10:
Figure supplement 1. Year-wise age distribution of influenza B viruses.
DOI: 10.7554/eLife.05055.016
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also comprises potential antigenic sites. Notably,
all changes in the closest cluster (21 Å) were
comprised exclusively of Victoria lineage amino
acid changes, while the few changes observed in
Yamagata lineage viruses were distant to the RBP
(Figure 11C). Overall, however, amino acid
changes in both influenza B virus lineages were
less frequent than those in influenza A viruses
sampled over a similar time period, with the
H3N2 viruses showing more extensive structural
change (Figure 11—figure supplement 1).
Notably, we also observed fundamental struc-
tural differences between the lineages (Figure 11B).
Crystal structures showed extensive backbone
differences around amino acid sites 165 and 180 that lie near the RBP as well as residue differences in
the helix close to where α-2,3 and α-2,6 ligands differ structurally, thereby potentially influencing
receptor binding (Figure 11D). Previous experiments suggest that Yamagata viruses bind pre-
dominantly to α-2,6-linked sialic acid host receptors while Victoria viruses have both α-2,3 and α-2,6
binding capacities (Wang et al., 2012; Velkov, 2013). Binding differences may also originate in part
from differences in N-glycosylation patterns between the lineages (Figure 11E, 12). While both
lineages share a possible glycan at Asn 160, only Victoria has a functional N-glycosylation site at Asn
248, although its distance from the receptor may account for only a limited role in binding differences.
On the other hand, N-glycosylation at Asn 212 occurs in both lineages but has a lower overall
frequency in Victoria strains. In light of the positive selection acting on codon sites 212 and 214 in the
Victoria lineage, it is interesting to note that amino acid changes in either site would abolish the
N-glycosylation at 212, thereby highlighting a possible functional consequence of gain or loss of
a glycan at this site. Furthermore, position 212 is located at the exit of the RBP which is used by
α-2,3-linked sialic acid host receptors, and loss of N-glycosylation at 212 consequently adds capacity
to bind α-2,3 and not just α-2,6-linked sialic acid host receptors (Figure 11E). Importantly, all our
sequenced viruses have been passaged in MDCK cells to avoid egg adaptation artifacts in this
context (Gambaryan et al., 1999). Interestingly, we observed that loss of N-glycosylation at site 212
was associated with an increased proportion in the younger (0–5 years) age group (Figure 12).
We therefore hypothesize that subtle differences in the prevalence of α-2,3- and α-2,6-linked glycans
on the cells of the respiratory tract of young children compared to adults (Nicholls et al., 2007;
Walther et al., 2013), combined with partial changes in glycosylation patterns, could account for
the observed differential age distribution of the two influenza B lineages.
Conclusions
The genomic and epidemiological data analyzed here provide important insights into the
phylodynamics of the two lineages of influenza B virus currently circulating in humans. In particular,
we find significant differences in the evolutionary and epidemiological dynamics between the Victoria
and Yamagata lineages (Table 3). Central to this is the observation that the phylodynamic pattern of the
Victoria lineage HA gene is indicative of a virus population under greater selection pressure that escapes
host immunity by accruing beneficial amino acid substitutions in the HA gene. Indeed, theory predicts
that the highest rate of viral adaptation occurs at intermediate levels of immune pressure (Grenfell
et al., 2004) which may characterize the Victoria lineage. Such an evolutionary pattern ensures that there
is a constant supply of susceptible individuals for Victoria lineage viruses—both naı̈ve and reinfected
individuals which in turn increases Re—which then exhibit a pattern of genomic diversity and lineage
turnover that is significantly faster and more periodic than Yamagata lineage viruses.
In contrast, the phylodynamic patterns exhibited by Yamagata viruses are indicative of a virus
population that exhibits slower and less periodic dynamics, reflected in a lower and more consistent
Re, in turn suggesting that these viruses are under weaker immune selection pressure and accordingly
experience weaker antigenic drift. Interestingly, clinical trials of influenza B virus vaccination in children
(Skowronski et al., 2011) and experimental infection of mice (Skowronski et al., 2012) showed that
the Yamagata antigens produced a stronger immune response than the Victoria antigens. If natural
Table 2. Age distribution by group
Victoria Yamagata
Age n % n % p value*
<6 1007 28.8 473 26.8
6–17 1361 39 402 22.7
≥18 1124 32.2 893 50.5
Total 3492 100 1768 100 <0.0001
*Age categories were compared by lineage using a χ2
test.
DOI: 10.7554/eLife.05055.017
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infection with influenza B virus was similar, this would imply that Yamagata viruses are less able to
evolve through antigenic drift and therefore escape the immune response (Grenfell et al., 2004).
We propose that these fundamental differences in evolutionary and epidemiological dynamics are
driven by differences in hemagglutinin binding preferences. Specifically, Victoria viruses appear to
have both α-2,3- and α-2,6-linked sialic acid binding capacities (Wang et al., 2012; Velkov, 2013),
Figure 11. Structural view of the HA showing mutational accumulation and lineage differences. Amino acid changes
observed within and between influenza B virus lineages (A). Arrow colours in (A) correspond to inter- (B) or intra- (C)
lineage amino acid changes, based on previously resolved crystal structure (PDB:4FQM). Amino acids in red represent
differences between the two lineages that were retained over all sampling years; yellow represents differences that are
newly observed in 2012 compared to 2002; and magenta represents changes lost in 2012 compared to 2002. Amino
acids in blue and green represent changes that occurred in Victoria and Yamagata viruses between 2002 and 2012,
respectively; whereas cyan represents difference between 2002 and 2012 shared between both lineages. These amino
acid changes occur in regions that cluster around 21, 29, and 37 Å distant from the RBP (C). Structural differences in RBP
among recent Victoria (B/Brisbane/60/2008) and Yamagata (B/Florida/4/2006) strains with a human-like α-2,6 host
receptor analogue (magenta) modeled within the viral RBP (D). D was based on crystal structures PDB:4FQM and PDB:
4FQJ with side-chains minimized after addition of ligand from PDB:2RFU through superposition. Regions differing in
backbone conformation are shown in orange for Victoria and cyan for Yamagata, while conserved regions are shown in
gray. Residues with conserved backbone structure but different amino acid side-chains are shown in red for Victoria and
blue for Yamagata. Side-chains are shown only for residues within 5 Å of the receptor ligand and differing between the
lineages. Structural view of receptor binding pocket with α-2,6- (green) and α-2,3-linked (red) host receptor and glycans
(blue) (E). E was based on crystal structure PDB:4FQM, with the addition of ligands from PDB:2RFU and PDB:2RFT
through superposition and no minimization. The presence of a glycan on site 212 allows binding only to 2,6-linked
receptors, while loss of the glycan allows binding to both α-2,3- and α-2,6-linked receptors. Brown arrows (B and C)
indicate relative position of receptor binding pocket (RBP), whereas black arrow heads (C and D) point to site of known
antigenic cluster transition (Koel et al., 2013).
DOI: 10.7554/eLife.05055.018
The following figure supplement is available for figure 11:
Figure supplement 1. Structural view of mutational drift in influenza A and B viruses.
DOI: 10.7554/eLife.05055.019
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while Yamagata viruses predominantly bind to α-2,6-linked glycans on cells in the human respiratory
tract. Experimental studies in children (aged up to 7) (Nicholls et al., 2007) and adults have shown
that the respiratory tissue of children mainly have α-2,3-linked receptors with a lower level of α-2,6-
linked receptors than adults, and these differences among the different age groups may in part
account for the different age distribution of the two B lineages. In turn, the greater propensity to
infect children will increase Re, initiating the epidemiological and evolutionary pattern that
characterizes the Victoria lineage. It remains to be determined whether the broadly equivalent
phylodynamic differences between the H3N2 and seasonal H1N1 types of influenza A virus are
similarly due to basic differences in the structure of their respective HA proteins. Furthermore, to
better understand the bimodal age distribution in Yamagata, where a significant reduction of infection
was observed among the older children–young adult group (<25 years), additional experimental
studies of the receptor distribution in all age groups are necessary.
Figure 12. Glycosylation at Asn 212 and correlation with age groups for Victoria viruses. Yamagata viruses showed
five instances of glycosylation loss at 212, compared to 71 instances in Victoria, hence Victoria lineage strains have
been analyzed in detail here. Temporal distribution of age groups and glycosylation at 212 for all Victoria strains (A).
Summary of odds ratio (OR) for association of glycosylation loss at 212 with the different age groups (B). OR values
>1 indicate that it is more likely to find a 212 loss in the respective age group, whereas values <1 indicate that 212
losses are less likely to be found in the respective groups. The following guideline helps judging significance of OR:
strong positive association >3; moderate positive association 1.5–3; moderate negative association 0.33–0.66;
strong negative association <0.33.
DOI: 10.7554/eLife.05055.020
Table 3. Summary of evolutionary and epidemiological characteristics of influenza B virus lineages
Characteristics Victoria Yamagata
Age distribution younger (mean 16.8, median 11) older (mean 26.6, median 18)
Genetic diversity strong seasonal changes weak seasonal changes
R (medians) higher (1.13–1.27) lower (1.08–1.14)
Positive selection stronger weaker
Antigenic drift relatively strong relatively weak
Reassortment high inter-sublineage reassortment, with
lower intra-sublineage reassortment
low inter-sublineage reassortment, with
greater intra-sublineage reassortment
Receptor binding preference α-2,3- and α-2,6-linked sialic acid mainly α-2,6 linked sialic acid
DOI: 10.7554/eLife.05055.021
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These observations have implications for the future control of influenza B virus in the human
population. While the co-circulation of divergent Yamagata viruses reported here has and can
confound the accurate selection of vaccine strains, our analyses also indicate that the Yamagata
viruses are under weaker positive selection and antigenic drift, and, on average, infect an older group
of people who are more likely to have a higher level of cross-reactive antibodies to the B lineage
viruses compared to children. As a consequence, there is a greater chance that, given sufficient
coverage, Yamagata viruses might experience a major drop in prevalence over time through targeted
control methods, such as the extensive use of quadrivalent influenza vaccines containing both
B lineages, in contrast to the more adaptable Victoria viruses.
Materials and methods
Surveillance
Influenza B positive samples collected between 2002 and 2013 from subjects in eastern Australia
(Victoria, New South Wales and Queensland) and from New Zealand and associated metadata,
including date of isolation and age of host, were sent to the WHO Collaborating Centre for Reference
and Research on Influenza, Melbourne, from National Influenza Centres and other laboratories as part
of the World Health Organization Global Influenza Surveillance and Response System (WHO GISRS).
Data deposited in Dryad data repository under DOI: 10.5061/dryad.n940b (Vijaykrishna et al., 2015).
Virus isolation
Influenza B viruses were isolated or re-isolated in MDCK cells (ATCC-CCL 34) from original clinical
samples or virus isolates and typed as B/Yamagata or B/Victoria using HI analysis or by molecular
assay (Deng et al., 2013). Viruses were stored at −80˚C until sequenced.
Sequencing of viral RNA genome
We sequenced the complete genomes of 908 laboratxory confirmed influenza B virus MDCK or MDCK-
SIAT cell propagated isolates passaged 1–4 times from eastern Australia and New Zealand using a novel
methodology (Zhou et al., 2014). Influenza B virus genomes were amplified using the universal influenza B
genomic amplification strategy that enables amplification of the complete genome of any influenza B virus
in a one-step single tube/well reaction. Specifically, RNA was isolated from 130 μl of culture supernatant
using ZR-96 Viral RNA Kit (Zymo Research, Irvine, CA) and eluted in 30 μl of RNase-free water. 3 μl of the
RNA was mixed with FluB Universal Primer Cocktail (Zhou et al., 2014) and converted to cDNA and
amplified with the SuperScript III One-Step RT-PCR System (Life Technologies, Grand Island, NY). The
amplicons were fragmented, flanked by sequencing adaptors, clonally amplified onto IonSphere particles,
and sequenced on the Ion Torrent PGMplatform following manufacturer’s instruction. The sequence reads
were sorted by bar code to separate different viruses and used to assemble viral genomes (sequence
accession numbers are available in the Dryad data repository under DOI: 10.5061/dryad.n940b).
Phylogenetic analysis
Sequences were curated, and maximum likelihood (ML) phylogenetic trees were inferred for each gene
segment independently from the samples described above. ML trees were estimated using iqtree v0.9.5
(Minh et al., 2013) using the best-fit nucleotide substitution model, chosen by the Bayesian Information
Criterion (BIC). The data were further divided into separate lineages (i.e., Victoria and Yamagata) and
time-scaled phylogenies and rates of nucleotide substitution for each were inferred using a relaxed
molecular clock model in a Bayesian Markov Chain Monte Carlo (MCMC) framework with the program
BEASTv1.8 (Drummond et al., 2012) that incorporates virus sampling dates to concurrently estimate
phylogenetic trees, rates of nucleotide substitution, and the dynamics of population genetic diversity
using a coalescent based approach. The analysis was conducted with a General Time Reversible (GTR)
model with a gamma (Γ) distribution of among-site rate variation and a time-aware linear Bayesian
skyride coalescent tree prior (Minin et al., 2008). We performed at least two independent analyses per
data set for 100 million generations sampled every 10,000 runs. After the appropriate removal of burn-in
(10–20% of samples in most cases), a summary Maximum Clade Credibility (MCC) tree was inferred and
visualized with Figtree v1.4 (Rambaut, 2014). Support for individual nodes is reflected in posterior
probability values, and statistical uncertainty is given by 95% Highest Posterior Density (HPD) intervals.
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The MCC trees were also used to estimate the genealogical pairwise diversity by averaging the time
distance between contemporaneous sample pairs with a 1 month window (Zinder et al., 2013).
The past population dynamics of each linage were compared using a Bayesian skyride analysis in
BEAST, which utilizes a Gaussian Markov Random Field (GMRF) smoothing prior to estimate the
changes in relative genetic diversity in successive coalescent intervals (Minin et al., 2008). In the
absence of natural selection (i.e., under a strictly neutral evolutionary process), the genetic diversity
measure obtained reflects the change in effective number of infections over time (Net, where t is the
average generation time). However, because natural selection can play a major role in the evolution of
the influenza HA, these are interpreted as ‘relative genetic diversity’, and which is consistent with
previous studies of influenza A virus (Rambaut et al., 2008). Sequence alignments with input
parameters are available under Dryad data repository under DOI: 10.5061/dryad.n940b.
Phylogeography and migration rate estimates
We used a continuous-time Markov chain (CTMC) phylogeographic process (Minin and Suchard, 2008;
Lemey et al., 2009) to estimate counts of migration to and from Australia and New Zealand, similar to
previous studies (Nunes et al., 2012; Bahl et al., 2013). Briefly, global influenza B virus HA sequences
and their associated spatial locations and isolation dates were downloaded from GenBank for the years
for which we estimated an effective reproductive number in the phylodynamic analysis (see below).
Spatial locations of the isolates were transformed to represent two discrete states: the region of interest
(Australia and New Zealand) and the rest of the world. Phylogeographic events were estimated
independently for each of the identified years using an asymmetric CTMC process (Minin and Suchard,
2008), with the estimated state transition counts (import and export) between the two discrete states
estimated using a Markov Jump count approach. This phylogeographic inference was implemented in
BEAST 1.8 (Drummond et al., 2012) similar to the temporal phylogenies described above. The resulting
log files were used in extracting the net migration counts and mean non-zero transition rates.
Phylodynamic analysis
To estimate epidemiological parameters (specifically the effective reproductive number, Re) for each
epidemic of virus lineages in Australia and New Zealand, we used the birth–death susceptible-
infected-removed (BDSIR) model (Kühnert et al., 2014). The BDSIR analysis was also conducted with
a GTR + Γ substitution model, with epidemiological dynamics estimated jointly with the phylogenies
for each virus lineage. The model assumes a closed SIR epidemic in each season for the underlying
host population. The initial number of susceptible individuals S0 could not be estimated and was
therefore initially fixed to 4,000,000 (results reported in the main text). Analysis under different S0
values, ranging from 40,000 to 10 million, showed that the estimates of reproductive numbers (Re) are
robust to the choice of S0. The BDSIR analyses utilized m = 100 intervals for the approximation of the
SIR dynamics. Incidence and prevalence were computed from the posterior distributions of the SIR
trajectories, and the relevant plots show their median values.
Molecular adaptation
Selection pressures for each gene segment, lineage, and individual codon were estimated as the ratio of
the number of nonsynonymous substitutions per nonsynonymous site (dN) to the number of synonymous
substitutions per synonymous site (dS). Estimates were obtained using the Single Likelihood Ancestor
Counting (SLAC) (Kosakovsky Pond and Frost, 2005) and Fast Unconstrained Bayesian AppRoximation
(FUBAR) (Murrell et al., 2013) methods, accessed through the Datamonkey webserver of the HyPhy
package (Delport et al., 2010). In addition, the dN/dS ratio for the internal and external branches of the
Victoria and Yamagata HA phylogenies was estimated separately using the CODEML program (two-
ratio model) available in the PAML suite (Yang, 2007).
HI assay and antigenic cartography
Representative viruses from each lineage were sub-sampled and tested for antigenic reactivity by
a hemagglutination inhibition (HI) assay using a panel of reference ferret antisera that were available
for each influenza B lineage (raw HI titers are available in the Dryad data repository under DOI:
10.5061/dryad.n940b) and the subsequent antigenic profile was used to generate antigenic maps
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(Cai et al., 2010) for each lineage. HI assays were performed as described previously (WHO Global
Influenza Surveillance Network, 2011) using panels of post-infection ferret sera raised against
representative viruses from both B/Victoria lineage or the B/Yamagata lineage collected from 2000 to
2013. Turkey red blood cells were used to detect unbound virus and the HI titer was determined as
the reciprocal of the last dilution that contained non-agglutinated RBC. Normalized titers from the HI
assay were compiled for antigenic cartography analysis. The HI matrix was used in a multi-dimensional
scaling (MDS) plot algorithm to chart the antigenic distances between isolates tested in a two-
dimensional map (Cai et al., 2010), through the AntigenMap webserver (Wan, 2010). To identify
residues contributing most to HI titer changes, pairwise comparison of sequences with a single amino
acid difference were conducted.
Computational structural modeling
Finally, sequence data of the HA segment from each lineage were used to construct structural models
(Krieger et al., 2009; Webb and Sali, 2014). To identify those residues that contribute most to
antigenic drift in Victoria viruses, we compared the HA amino acid sequences of all pairs of HI assay
tested strains using the Smith-Waterman algorithm. If only a single mutation difference was found, we
calculated the respective average HI titer change for occurrences of this mutation. These amino acid
sites were then mapped on the crystal structure PDB:4FQM (Dreyfus et al., 2012) and visualized
using YASARA (Krieger et al., 2009).
Amino acid substitutions per site between pairs of HA sequences were calculated using MEGA5
(Tamura et al., 2011) under the Jones-Taylor-Thornton (JTT) amino acid substitution model. We
constructed structural models using MODELLER (Webb and Sali, 2014) (five models each with and
without ligand, best model selected by DOPE quality score), structural alignments were conducted
using MUSTANG (Konagurthu et al., 2006) and visualized using YASARA (Krieger et al., 2009). To
identify structural changes occurring on the HA proteins of influenza A subtypes and influenza B virus
lineages over a 10-year period, we selected the HA protein sequences of the following virus strains:
influenza B Victoria lineage, B/Sydney/1/2002 and B/Sydney/205/2012; Yamagata lineage, B/Victoria/
341/2002 and B/Victoria/831/2012; influenza A H1N1 virus, A/Brisbane/59/2007 and A/Malaysia/11641/
1997 and influenza A H3N2 virus, A/Perth/16/2009 and A/Moscow/10/1999. Crystal structure templates
used for computational modeling include PDB:4FQM (Dreyfus et al., 2012) (influenza B virus), PDB:
3UBE (Xu et al., 2012) (H1N1), and PDB:2YP4 (Lin et al., 2012) (H3N2).
Differences in the receptor binding pocket region of the two influenza B lineages were visualized
using B/Brisbane/60/2008 (PDB:4FQM [Dreyfus et al., 2012]) and B/Florida/4/2006 (PDB:4FQJ
[Dreyfus et al., 2012]) with the addition of an α-2,6-linked host receptor analogue ligand from
a known complex (PDB:2RFU [Wang et al., 2007]) and targeted side-chain minimization of residues
within 8 Å of the ligand through short simulated annealing molecular dynamic simulations in YASARA
(Krieger et al., 2009) as previously benchmarked to ensure realistic results.
We also used YASARA (Krieger et al., 2009) to visualize the role of glycosylation on Asn at
position 212 for α-2,3- vs α-2,6-linked host receptor ligands by schematically superimposing both
ligands (PDB:2RFT [Wang et al., 2007] and PDB:2RFU [Wang et al., 2007]) into their respective
positions within the receptor binding pocket of a fully glycosylated influenza B HA head (PDB:4FQM
[Dreyfus et al., 2012]).
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Kühnert D, Stadler T, Vaughan TG, Drummond AJ. 2014. Simultaneous reconstruction of evolutionary history and
epidemiological dynamics from viral sequences with the birth-death SIR model. Journal of the Royal Society,
Interface 11:20131106. doi: 10.1098/rsif.2013.1106.
Lemey P, Rambaut A, Drummond AJ, Suchard MA. 2009. Bayesian phylogeography finds its roots. PLOS
Computational Biology 5:e1000520. doi: 10.1371/journal.pcbi.1000520.
Lin YP, Xiong X, Wharton SA, Martin SR, Coombs PJ, Vachieri SG, Christodoulou E, Walker PA, Liu J, Skehel JJ,
Gamblin SJ, Hay AJ, Daniels RS, McCauley JW. 2012. Evolution of the receptor binding properties of the
influenza A(H3N2) hemagglutinin. Proceedings of the National Academy of Sciences of USA 109:21474–21479.
doi: 10.1073/pnas.1218841110.
McCauley JW, Hongo S, Kaverin NV, Kochs G, Lamb RA, Matrosovich MN, Perez DR, Palese P, Presti RM, Rimstad E,
Smith GJ. 2012. Family - Orthomyxoviridae. In: King AMQ, Lefkowitz E, Adams MJ, Carstens EB, editors. Virus
taxonomy: ninth report of the international committee on taxonomy of viruses. San Diego: Elsevier. p. 749–761.
Minh BQ, Nguyen MA, von Haeseler A. 2013. Ultrafast approximation for phylogenetic bootstrap. Molecular
Biology and Evolution 30:1188–1195. doi: 10.1093/molbev/mst024.
Minin VN, Bloomquist EW, Suchard MA. 2008. Smooth skyride through a rough skyline: bayesian coalescent-based
inference of population dynamics.Molecular Biology and Evolution 25:1459–1471. doi: 10.1093/molbev/msn090.
Minin VN, Suchard MA. 2008. Counting labeled transitions in continuous-time Markov models of evolution. Journal
of Mathematical Biology 56:391–412. doi: 10.1007/s00285-007-0120-8.
Murrell B, Moola S, Mabona A, Weighill T, Sheward D, Kosakovsky Pond SL, Scheffler K. 2013. FUBAR: a fast,
unconstrained bayesian approximation for inferring selection. Molecular Biology and Evolution 30:1196–1205.
doi: 10.1093/molbev/mst030.
Nelson MI, Edelman L, Spiro DJ, Boyne AR, Bera J, Halpin R, Sengamalay N, Ghedin E, Miller MA, Simonsen
L, Viboud C, Holmes EC. 2008a. Molecular epidemiology of A/H3N2 and A/H1N1 influenza virus during
a single epidemic season in the United States. PLOS Pathogens 4:e1000133. doi: 10.1371/journal.ppat.
1000133.
Nelson MI, Viboud C, Simonsen L, Bennett RT, Griesemer SB, St George K, Taylor J, Spiro DJ, Sengamalay NA,
Ghedin E, Taubenberger JK, Holmes EC. 2008b. Multiple reassortment events in the evolutionary history of
H1N1 influenza A virus since 1918. PLOS Pathogens 4:e1000012. doi: 10.1371/journal.ppat.1000012.
Neumann G, Noda T, Kawaoka Y. 2009. Emergence and pandemic potential of swine-origin H1N1 influenza virus.
Nature 459:931–939. doi: 10.1038/nature08157.
Nicholls JM, Bourne AJ, Chen H, Guan Y, Peiris JS. 2007. Sialic acid receptor detection in the human respiratory
tract: evidence for widespread distribution of potential binding sites for human and avian influenza viruses.
Respiratory Research 8:73. doi: 10.1186/1465-9921-8-73.
Nunes MR, Faria NR, Vasconcelos HB, Medeiros DB, Silva de Lima CP, Carvalho VL, Pinto da Silva EV, Cardoso JF,
Sousa EC Jr, Nunes KN, Rodrigues SG, Abecasis AB, Suchard MA, Lemey P, Vasconcelos PF. 2012.
Phylogeography of dengue virus serotype 4, Brazil, 2010-2011. Emerging Infectious Diseases 18:1858–1864.
doi: 10.3201/eid1811.120217.
Osterhaus AD, Rimmelzwaan GF, Martina BE, Bestebroer TM, Fouchier RA. 2000. Influenza B virus in seals. Science
288:1051–1053. doi: 10.1126/science.288.5468.1051.
Paul Glezen W, Schmier JK, Kuehn CM, Ryan KJ, Oxford J. 2013. The burden of influenza B: a structured literature
review. American Journal of Public Health 103:e43–51. doi: 10.2105/AJPH.2012.301137.
Rambaut A. 2014. Figtree. URL http://tree.bio.ed.ac.uk/software/figtree/.
Rambaut A, Pybus OG, Nelson MI, Viboud C, Taubenberger JK, Holmes EC. 2008. The genomic and
epidemiological dynamics of human influenza A virus. Nature 453:615–619. doi: 10.1038/nature06945.
Rota PA, Wallis TR, Harmon MW, Rota JS, Kendal AP, Nerome K. 1990. Cocirculation of two distinct evolutionary
lineages of influenza type B virus since 1983. Virology 175:59–68. doi: 10.1016/0042-6822(90)90186-U.
Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC,
de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, Lapedes AS, Lin YP, Mosterin A, Obuchi M,
Odagiri T, Osterhaus AD, Rimmelzwaan GF, Shaw MW, Skepner E, Stohr K, Tashiro M, Fouchier RA, Smith
DJ. 2008. The global circulation of seasonal influenza A (H3N2) viruses. Science 320:340–346. doi: 10.1126/
science.1154137.
Skowronski DM, Hamelin ME, Janjua NZ, De Serres G, Gardy JL, Rhéaume C, Bouhy X, Boivin G. 2012. Cross-
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